tiprankstipranks
Rakovina Therapeutics Inc (TSE:RKV)
:RKV
Canadian Market

Rakovina Therapeutics Inc (RKV) Income Statement

Compare
12 Followers

Rakovina Therapeutics Inc Income Statement

Last quarter (Q3 2024), Rakovina Therapeutics Inc's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Rakovina Therapeutics Inc's net income was $-1.02M. See Rakovina Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21
Total Revenue
$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―
Depreciation and Amortization
$ 536.11K$ 536.11K$ ―
EBITDA
$ -1.93M$ -2.26M$ -5.11M
Operating Income
$ -2.48M$ -2.82M$ -2.47M
Other Income/Expenses
$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―
Net Income
$ -2.61M$ -2.79M$ -5.52M
Per Share Metrics
$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Rakovina Therapeutics Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis